Adverum Biotechnologies to Present at Upcoming Investor Conferences
February 19 2020 - 4:01PM
Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene
therapy company targeting unmet medical needs in ocular and rare
diseases, today announced the company will present at two upcoming
investor conferences:
Investor Presentation: SVB
Leerink 9th Annual Global Healthcare Conference 2020Date:
Tuesday, February 25, 2020Time: 9:00 am ESTLocation: New York,
NYWebcast: A live audio webcast will be accessible under Events and
Presentations in the Investors section of the company's website.
The archived audio webcast will be available on the Adverum website
following the presentation for 30 days.
Investor Presentation:
Cowen & Co. 40th Annual Healthcare
ConferenceDate: Tuesday, March 3, 2020Time: 8:40 am
ESTLocation: Boston, MAWebcast: A live audio webcast will be
accessible under Events and Presentations in the Investors section
of the company's website. The archived audio webcast will be
available on the Adverum website following the presentation for 30
days.
About Adverum
BiotechnologiesAdverum Biotechnologies (Nasdaq: ADVM) is a
clinical-stage gene therapy company targeting unmet medical needs
in serious ocular and rare diseases. Adverum is evaluating its
novel gene therapy candidate, ADVM-022, as a one-time, intravitreal
injection for the treatment of its lead indication, wet age-related
macular degeneration. For more information, please visit
www.adverum.com.
Investor and Media
Inquiries:Investors:Myesha LacyAdverum Biotechnologies,
Inc.mlacy@adverum.com1-650-304-3892
Media:Cherilyn Cecchini, M.D.LifeSci
Communicationsccecchini@lifescicomms.com 1-646-876-5196
Adverum Biotechnologies (NASDAQ:ADVM)
Historical Stock Chart
From Aug 2024 to Sep 2024
Adverum Biotechnologies (NASDAQ:ADVM)
Historical Stock Chart
From Sep 2023 to Sep 2024